Clinical Trial Update: HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer [EARLY_Phase 1]

View source ↗

Summary

HFHS-1801-A, an early-phase pilot study evaluating immunotherapy as consolidation therapy for recurrent head and neck cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Henry Ford Health System | Conditions: Head and Neck Neoplasms | EARLY_Phase 1 | Status: COMPLETED